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A concept that compounds commonly present in biological sys-
tems lack genotoxic and mutagenic activities is generally in use, hence a 
low number of endogenous substances have ever been tested to 
mutagenicity. Epidemiological and experimental analyses indicated, how-
ever, that sexual steroids could contribute to initiation and/or continuation 
of malign diseases. Detailed studies using methods of biochemistry, mo-
lecular biology, cytogenetics and other branches, showed that not only 
epigenetic mechanisms, such as a stimulation of cell proliferation, but 
also certain hormones, that can express genotoxic effects, such as cova-
lent DNA modification, then chromosomal lesions and chromosomal ab-
errations, are in the background of malign transformation under activities 
of hormones. In the case of oestrogens, it was shown that excessive hor-
monal stimulation led to a metabolic conversion of these hormones to re-
active intermediates with formation of reactive oxygenic derivates, so that 
cells were virtually under conditions of oxidative stress. Individual and 
tissue susceptibility to occurrence of deterioration of DNA and other cell 
components generally results from the differences in efficiency of en-
zymic and non-enzymic mechanisms of resistance against oxidative 
stress. Besides, steroid, thyeroid hormones and catecholamine (dopamine, 
noradrenaline/norepinephrine and adrenaline) can express genotoxic ef-
fects in some test-systems. It is interesting that all above mentioned hor-
mones have a phenolic group. Data on possible genotoxic effects of pep-
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tide and protein hormones are very scarce, but based on the available li-
terature it is considered that this group of hormones probably lacks 
mutagenic activities. The possibility that hormones, as endogenous sub-
stances, express mutagenic activities results from the fact that DNA is, 
regardless of chemical and metabolic stability, susceptible, to a certain 
extent, to changeability compatible with the processes of the biological 
evolution. 
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INTRODUCTION 
Two essential organic systems - nervous and endocrine - contributing to 
regulation of physiological processes and integration of an organism as an entity 
were developed during the evolution of animals. Concerning the fact that hormones 
are included into regulation of a number of living processes and a generally ac-
cepted concept that hormones are phylogenetically elder than functions that are 
under their control, it is necessary to ask a question whether hormones can, by their 
impacts, contribute to the formation of mutations at the level of the genetic mate-
rial. Although sufficiently efficient mediators and endocrine regulators selected 
during the evolution of animals do not disturb genetic integrity, experimental and 
epidemiological analyses indicate that previously stated possibility could be real. 
At present, it is clear that beside a great number of environmental 
genotoxic chemical agents some substances, ordinarily present in the animal or 
human organism, can express genotoxic and mutagenic effects. Considering that 
these substances are compounds, normally included into regulation of biochemical 
and physiological processes, intermediates and metabolic products, they are called 
endogenous mutagenes. 
It is known that a relatively good correlation between mutagenesis and 
carcinogenesis exits. Therefore, data indicated associations between some types of 
cancer and the application of hormones could point out to a certain mutagenic po-
tential. Hence, data of experiments with cultured cells, certain species of rodents, 
as well as, results on extensive epidemiological and endocrinological studies in 
humans, pointed to an effect of hormones in originating and/or maintenance of 
malignly transformed cells (HENDERSON et al., 1982). According to some authors 
(KEY and BERAL, 1992), hormonal effects in originating of malign diseases signify 
effects at the level of carcinogenesis processes promotion, which is in conformity 
with negative results obtained by tests of hormones for genotoxicity in certain sys-
tems (BRAUN, 1977; BARRET et al., 1981; HERZOG and LEUSCHNER, 1995; ĐELIĆ, 
2001). On the other hand, there are literature data on genotoxic effects of hormones 
(MCQUARRIE et al., 1970; VAN ASWEGEN et al., 1989; BALI et al., 1990; TSUTSUI 
et al., 1990; ĐELIĆ and ĐELIĆ, 2002) that stimulated researchers to consider a pos-
sible role of hormones in carcinogenesis initiation.  
The differences in obtained test results on hormones for genotoxicity can 
be caused by limitations of test-systems themselves, different reactivity under in N.ĐELIĆ: MECHANISM OF GENOTOCSIC EFFECTS OF HORMONES  61 
vitro and in vivo conditions, possibilities of existence of tissue and species-speci-
ficities in expressing of genotoxic effects. 
The studies on mutagenic effects of hormones were performed in different 
in vitro and in vivo systems, form bacteria to mammals. The selection of hormones 
encompassed mainly steroids due to an obvious correlation between occurrences of 
certain types of malignity and the use of natural and synthetic hormones in the 
therapy. The present paper displays in detail a mechanism of genotoxic effects of 
oestrogenic hormones, since they are observed best, while literature data on non-
steroid hormones are very modest. 
MECHANISM OF GENOTOXIC EFFECTS OF OESTROGENS 
The application of the current methods of biochemistry and molecular bi-
ology has opened a new field that contributed to highlighting molecular mutagene-
sis and carcinogenesis under effects of steroids. According to today's available lit-
erature data, oestrogens have been studied to the highest degree. 
A greater number of substances of different chemical structures expresses 
the activity of oestrogenic hormones. Estradiol (E2) and estron are the major natu-
ral oestrogens produced in ovaries. Synthetic oestrogens can be steroidal, such as 
17α ethynil estradiol - an oestrogenic component of many contraceptives, or non-
steroidal, such as diethylstilbestrol and hexestrol (Fig. 1).  
 
Figure 1. Structural formulae of the most important natural (A) and synthetic (B) oestrogens 
 
Besides, phenols with a certain oestrogenic activity were either discovered 
in plants or were chemically synthesised (DODDS et al., 1983; BRADBURY and 
WHITE, 1954). Hormonal effects of this large group of substances are revealed by 
either the affinity for oestrogenic receptors or biological responses characteristic 
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Normal physiological responses are achieved by means of E2 or potential 
synthetic estrogens at very low concentrations. At higher dosages, however, estro-
gens induce tumours in experimental animals (WALKER, 1983), i.e. result in car-
cinogenic effects in humans (IARC, 1979). 
Even though effects of hormones in formation of neoplasms mainly occur 
at the level or promotion process (KEY and BERAL, 1992), data obtained from vari-
ous tests for genotoxicity indicate to a possible role of carcinogenesis initiation.  
The greatest number of studies on oestrogen-induced carcinogenesis has 
been performed on a model of renal tumour in hamsters. Although spontaneous 
initiation of renal cancer is a very rear phenomenon in this species, predisposition 
to oestrogen-induced carcinogenesis of kidney cortex was observed (KIRKMAN, 
1959). It is also interesting that there is no correlation between the hormonal activ-
ity strength of oestrogens and their ability to induce tumours (LI and LI, 1984). 
Therefore, it was assumed that beside effects induced by oestrogenic receptors, that 
could be the base of the epigenetic mechanisms, there are certain processes regu-
lating mutagenic activities of oestrogenic hormones (METZLER and MCLACHLAN, 
1978). 
The presently actual apprehension is that metabolic reactions at signifi-
cantly higher concentrations of oestrogens, in which free radicals are generated, 
become predominant biochemical processes that overlays their hormonal effects. 
Forasmuch as oestrogens are phenols, metabolism of their phenolic groups can, at 
higher concentrations of oestrogens, express harmful effects in cells, including 
damaging of DNA molecules (LIEHR and ROY, 1990). 
Redox cycling, generating free radicals, is base of genotoxic effects of 
oestrogens and similar compounds. Prior to its involvement into redox cycling, 
estradiol is converted to catecholestrogen by the activity of the enzyme oestrogen 
hydroxylase (Fig. 2). In contrast, diethylstilbestrol (DES) presents hydroquinone 
capable to be directly involved into redox reactions. 
 
Figure 2. Conversion of estradiol to catecholestrogen (CE) 
1 - estrogen 2-hidoxilase; 2 - estrogen 4-hydroxylase N.ĐELIĆ: MECHANISM OF GENOTOCSIC EFFECTS OF HORMONES  63 
Catecholestrogens (CE) and DES can be oxidised to the appropriate 
quinones by means of peroxidases and H2O2 (LIEHR et al., 1983) or cytochrome P-
450 oxidase and organic hydroperoxids (LIEHR et al., 1986). It is assumed that 
semiquinones represent intermediates in this process, but this cannot be yet proven 
by available techniques. Superoxide radical ( ), formed during conversion of 
semiquinone to quinone in the presence of molecular oxygen (O2) (ROY and LIEHR, 
1988), can be, under appropriate conditions, further transformed into hydroxyl 
radical (
.
OH). The completion of redox cycling is provided by the reduction of 
quinones over semiquinones to DES and CE (i.e. hydroquinones by the activity of 
NADPH dependent cytochrome P-450 reductases) (POWIS and APPEL, 1980). Be-
sides, quinone reductase (DT-diaphorase) reduces DES Q directly to Z-DES by the 
transfer of two electrons, without formation of semiquinonic intermediate (Fig. 3 
and 4). 
-
2 O
 
Figure 3. Redox cycling between DES and DES Q (DES quinone) and generation of free 
radicals; 1-cytochrome P 450 oxidase, 2-NADPH dependent cytochrome P450 reductase; 3-
quinone reductase; E-DES and Z-DES present stereoizomeric DES forms; Z,Z-dienestrol is 
spontaneously formed from DES Q; DES Q - diethylstilbestrol-4', 4'' quinone 
    
It is known that generation of reactive radicals results in damages of DNA 
molecule (SMITH et al., 1985). The formation of covalent DNA additive products 
(adducts) is a key step in the initiation of carcinogenesis (BROKKES and LOWLEY, 
1964). Therefore, different experimental approaches were used in order to contrib-
ute to a better understanding of interactions between metabolic products of oestro-
genic hormones and DNA molecules. A 
32P-postlabelling method (RANDERATH 
and RANDERATH, 1994) greatly contributed to a detection of covalently modified 
nucleotides. The enzymic hydrolysis of DNA to 3'-mononucleotides is the first step 
in this method. Then, these 3'-mononucleotides are converted to 5-
32P-labelled 3'5'-
biphosphate derivetes by the action of T4 polynucleotide kinase in the presence of 
[γ-
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change thin layer chromatography (TLC). The detection of DNA adducts is then 
done by autoradiography. In such a way, it is possible to detect 1 aromatic adduct 
in ≈ 10
9 normal DNA nucleotides (approximately 10 adducts in the mammalian 
genome, RANDERATH et al., 1985). The existence of three different groups of DNA 
covalent modifications was determined by the application of the 
32P-postlabelling 
method and other methods for analysing DNA isolated from animals treated with 
oestrogens (LIEHR et al., 1993). 
 
Figure 4. Metabolic conversion of estradiol to CE and redox cycling; 1-estradiol, 2-
hydroxylase; 2-cytochrome P 450 oxidase; 3-NADPH dependent cytochrome P 450 
reductase 
 
The first group consists of nucleotides covalently bound to reactive deri-
vates of hormones themselves. In such a way, it was detected that a single high 
dosage of DES produced a specific set of DNA adducts in liver, kidney and uterus 
of hamsters (GLADEK and LIEHR, 1989). The identical set of modified bases can be 
obtained if purified DNA or dGMP are incubated with DES quionone (DES Q), a 
major DES metabolite under in vitro and in vivo conditions. Accordingly, DES is 
metabolically activated in vitro to DES Q, which can be then bound to DNA. The 
investigation of the intensity of covalent binding of DES Q to different DNA frag-
ments showed a high level of base modification in oligonucleotides rich in guanine 
and c-myc protooncogene, while a significantly lower level of DNA addition prod-
ucts was registered in c-fos protooncogenes (Bhat et al., 1992).  
LIEHR  et al. (1993) classified so-called oestrogen-induced endogenous 
DNA adducts into the second group of modified nucleotides. These DNA adducts 
occur in kidneys of hamsters chronically treated with oestrogens for several 
months. The occurrence of these modifications of DNA molecules precedes mor-
phologically detectable malign cells. The fact that structurally different oestrogens 
induce the occurrence of the identical set of modified nucleotides is especially in-
teresting. Therefore, it is considered that oestrogens, in fact, induce the formation 
of electrophylic reactants capable to damage the DNA molecule. Chemical nature N.ĐELIĆ: MECHANISM OF GENOTOCSIC EFFECTS OF HORMONES  65 
of endogenous substances has not been determined yet, although there are some 
indications (on the basis of chromatographic motility of modified nucleotides) that 
they can be derivates of lipids or lipid peroxides (WANG and LIEHR, 1995). 
The third group of modification in DNA is initiated due to covalent dam-
ages caused by oxygenic free radicals that are released during redox cycling of 
oestrogens. Semiquinone intermediates are free radicals promoting the formation 
of superoxide radical ( ) out of oxygen (O2) that can be converted to H2O2 by 
the action of superoxide dismutase (SOD). Although both,   and H2O2 are suffi-
ciently reactive to cause damages to biomolecules, hydroxyl radical (
.
OH) that can 
be generated form H2O2 by means of metal cations, is even more reactive (IMLAY 
and LINN, 1988). In terms of the experimental data that the level of 8-hydroxyde-
oxyguanosine (8-OH-dGuo) significantly increases with incubation of DNA, mi-
crosomes, NADPH and DES Q in the presence of FeCl3, ROY et al. (1991) as-
sumed that 
.
OH regulated hydorxilation of guanine (Fig. 5). The same authors 
showed that the level of 8-OH-dGuo elevated in Syrian hamsters treated by dieth-
ylstilbestrol (DES). The elevated level of 8-OH-dGuo requires the increase of 
metabolic activities that maintain redox cycling and generation of free radicals 
and/or decrease activity of DNA reparation mechanisms.  
-
2 O
-
2 O
 
Figure 5. Suggested mechanism of hydroxylation of guanine base due to DES redox cycling; 
dG-deoxyguanosine; Enzymes: 1-cytochrome P 450 oxidase, 2-cytochrome P 450 reducase; 
3- superoxide dismutase (SOD); 4-catalase; 5-quinone reductase (ROY et al., 1991) 
 
The Figure 6 shows the principal processes controlling genotoxicity of 
oestrogens. However, it is necessary to mention that realisation of genotoxic po-
tential of oestrogenic hormones depends, to a great extent, on a level of activities 
of enzymes involved into conversion of steroidal oestrogens to EC, enzymes that 
perform detoxication of free radicals and non-enzymic mechanisms of free radicals 
elimination. 
Mechanisms of protection that can decrease occurrence of semiquinoines 
and quinones imply the elimination of catecholestrogens (CE) by methylation with 
catechol-O-methyltransferase (COMT, Fig. 7) or by other reactions of conjugation 
with glutathione, glucuronide and sulphate (LIEHR, 1990). It was shown that 4-
hydroxyestradiol mainly occurs as a product of hydroxylation of oestrogens in or-
gans prone to oestrogen-induced carcinogenesis (LIEHR and RICCI, 1996). 
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Figure 6. Suggested mechanism of genotoxicity of oestrogens (LIEHR, 1990). Steroidal 
oestrogens convert to catecholestrogens (CE) by means of 2- and 4-hydroxylase(1). Free 
radicals generate in redox cycling between CE or DES and their quinone. Cytochrome P 450 
oxidase catalyses oxidation (2), while cytochrome P 450 reductase (3) or quinone reductase 
(4) catalyse reduction. 
 
 
Figure 7. Methylation of catecholestrogens with catechol-O-methyltransferase (COMT) in 
the presence of S-adenosylmethionine (SAM) (ROY et al., 1990); 2-OH-E2 - 2-
hydroxyestradiol; 4-OH-E2 4-hydroxyestradiol; 2-MeO-E2 - 2-methoxyestradiol; 2-OH-E2 -
3Me - 2-hydroxyestradiol 3-methyl ether; 4- MeO-E2 - 4-methoxyestradiol; 4-OH-E2 -3Me - 
4-hydroxyestradiol 3-methyl ether 
 
Chronic administration of estradiol to Syrian hamsters reduces renal oes-
trogen 4-hydroxylase activity by about 25%, while the level of 2-hydroxylase de-
creases by 75% in relation to control values. The elevated level of 4-hydroxyestra-
diol (4-OH-E2) is a final result. Besides, it is important to emphasise that 2-OH-E2 
(ROY et al., 1990) and catecholamines (ZHU and LIEHR, 1993) inhibit methylation 
of 4-OH-E2 by which physiological inactivation by COMT is reduced. Enzymic 
changes that facilitate the initiation of DNA covalent damages also include a tem-
porary decrease in renal quinone reductase and catalase activity with the increase N.ĐELIĆ: MECHANISM OF GENOTOCSIC EFFECTS OF HORMONES  67 
of glutathione peroxidase activity. In such a way, estradiol disturbs the balance of 
enzymic mechanisms of protection against oxidative stress (ROY and LIEHR, 1989). 
The effect of vitamin C as a non-enzymic mechanism that reduces 
genotoxicity of oestrogens is very interesting. The DES Q concentration in ham-
sters excessively treated with vitamin C reduces by approximately 50% following 
DES activity, which corresponds to the reduction of renal tumour incidence by 
50% (LIEHR et al., 1989). The effect of vitamin C is attributed to non-enzymic 
mechanisms of DES Q reduction, as well as, to capability to remove superoxide 
radical (LIHER, 1991). 
A special significance for maintenance of redox cycling of oestrogens 
belongs to lipid peroxidation. Lipid peroxides, formed under effects of free radicals 
(probably 
.
OH), can then serve as cofactors for CE of DES oxidation to sem-
quinones and quinones. Furthermore, discovered oestrogen 2/4-hydroxylasede-
pendent on organic hydroperoxides induce CE formation by oxidation of oestro-
gens. As a result of all these processes, redox cycling of oestrogens is a self-pre-
servative process in which free radicals are generated and are capable to form lipid 
peroxides, which will support redox cycling itself until steroid hormones enter the 
cell (KAPPUS, 1985; LIEHR and ROY 1990). 
In the end, the question on whether reactions in redox cycling of oestro-
gens have any physiological role or no arises. It is well-known that almost all bio-
chemical phenomena occurring during carcinogenesis have, at least during a cer-
tain period of the individual development, important and necessary roles in cell 
cycling and in the organism generally. Unfortunately, the information on possible 
physiological significance of redox cycling of CE and generation of free radicals 
today is inferior to knowledge on pathophysiological modifications that are the 
base of malign transformation. 
However, there are some indications that catecholestrogens (CE) can 
function as local mediators in physiological and pathophysilogical responses to 
oestrogenic hormones (WEISZ, 1991). For instance, it was suggested that CE as-
sisted in the maturation of phyllocula (SPICER and HAMMOND, 1989) and implan-
tation of blastocysts (PARIA et al., 1990). One of possible roles of free radicals 
could be related to their participation in parturition inducements. There are evi-
dences that prostaglandins are involved in the parturition (NOVY and LIGGINS, 
1980) and that hydrogen peroxide supports uterus contractions by stimulation of 
the prostaglandin production (CHEROUNY et al., 1988). These processes are possi-
bly amplified by CE over stimulation of prostaglandin synthesis in the uterus 
(PAKRASI and DEY, 1983). Further studies are necessary for more accurate and 
detailed determinations of a possible physiological importance of redox cycling. 
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Izvod 
Često se polazi od shvatanja da jedinjenja koja su normalno prisutna u 
biološkim sistemima nemaju genotoksične i mutagene efekte, tako da je mali broj 
endogenih supstanci testiran na mutagenost. Epidemiološke i eksperimentalne 
analize ukazale su, me|utim, da seksualni steroidi mogu da doprinesu nastanku i/ili 
održavanju malignih oboljenja. Podrobnija ispitivanja primenom metoda bio-
hemije, molekularne biologije, citogenetike i drugih disciplina otkrila su da se u 
osnovi maligne transformacije pod dejstvom hormona ne nalaze samo epigenetički 
mehanizmi poput stimulacije deobe ćelija, već neki hormoni mogu da ispolje 
genotoksične efekte kao što su kovalentne modifikacije DNK, oštećenja hromo-
zoma i hromozomske aberacije. U slučaju estrogena, pokazano je da prekomerna 
hormonska stimulacija vodi ka metaboličkoj konverziji ovih hormona do reaktiv-
nih intermedijera uz nastanak reaktivnih kiseoničnih derivata, tako da se ćelije 
praktično nalaze u uslovima oksidativnog stresa. Individualna i tkivna osetljivost 
ka nastanku oštećenja DNK i drugih komponenti ćelije, uglavnom proisitče iz 
razlika u efiksanosti enzimskih i neenzimskih mehanizama odbrane od oksidativ-
nog stresa. Pored steroidnih, tieroidni hormoni i kateholamini (dopamin, 
noradrenalin i adrenalin) mogu da ispolje genotoksične efekte u nekim test-sis-
temima. Interesanto je da svi gore navedeni hormoni imaju fenolnu grupu. Podaci o 
mogućim genotoksičnim efektima peptidnih i proteinskih hormona veoma su 
oskudni, ali se na osnovu raspoložive literature smatra da ova grupa hormona 
verovatno nema mutagene efekte. Mogućnost da hromoni kao endogene supstance 
ispolje mutagene efekte proističe iz toga što je DNK pored hemijske i metaboličke 
stabilnosti podložna izvesnom stepenu promenljivosti kompatibilnom sa procesima 
biološke evolucije. 
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